삼성서울병원

Ko En

비뇨의학과 강민용 교수

진료분야
신장암, 전립선암, 비뇨종양의학, 로봇수술, 복강경수술
진료일정 12 月
날짜
01
02
03
04
05
06
07
08
09
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
오전
오후
진료일정 01 月
날짜
01
02
03
04
05
06
07
08
09
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
오전
오후

학력

학력
2014.08 카이스트 의과학대학원 박사
2010.02 서울대학교 의과대학 대학원, 석사
2005.02 서울대학교 의과대학 의학과 학사

경력

경력
2019.09 ~현재 삼성융합의과학원(SAHIST) 융합의과학과 겸직 교수
2019.03 ~현재 성균관의대, 삼성서울병원 비뇨의학과 조교수
2019.04 ~ 2019.04 Havard Medical School, Boston Children’s Hospital (Boston, MA, USA) 연수
2018.03 ~ 2019.02 삼성서울병원 비뇨의학과 전임대우조교수
2017.03 ~ 2018.02 삼성서울병원 비뇨의학과 임상전임강사
2016.03 ~ 2017.02 서울대학교병원 비뇨의학과 임상강사
2015.03 ~ 2016.02 분당서울대학교병원 비뇨의학과 임상강사
2014.05 ~ 2015.02 서울대학교병원 비뇨의학과 임상강사
2010.03 ~ 2014.04 KAIST 생명과학과 발생분화연구실 연구원 (전문연구요원)
2010.03 비뇨의학과 전문의 자격 취득
2006.03 ~ 2010.02 서울대학교병원 비뇨의학과 전공의
2009.06 Johns Hopkins Hospital (Baltimore, Maryland, USA) 연수
2005.03 ~ 2006.02 서울대학교병원 인턴 (수련의)

학회활동

학회활동
2020.07 ~ 현재 대한암학회 연구위원회 위원
2020.07 ~ 현재 대한비뇨기초의학 연구회 국제교류 이사
2019.08 ~ 현재 대한비뇨기종양학회 학술위원회 위원
2018.10 ~ 현재 Urological Research Society 정회원
2018.09 ~ 현재 대한비뇨기종양학회 부총무
2018.04 ~ 현재 대한암학회 평생회원
2017.10 ~ 현재 대한비뇨의학회 학술위원
2014.05 ~ 현재 대한비뇨기종양학회 정회원
2014.05 ~ 현재 대한비뇨기계-기초의학연구회 정회원
2010.03 ~ 현재 대한비뇨의학회 정회원

수상이력

수상이력
2020.10 대한비뇨기종양학회 정기학술대회 연제발표 우수상
2019.10 대한비뇨의학회 학술상 (국외논문 임상 우수상)
2019.08 대한비뇨기종양학회 정기학술대회 연제발표 우수상
2019.08 대한비뇨기종양학회 정기학술대회 공모논문 대상
  • TECHNOL CANCER RES T 2021 10.1177/15330338211024660 Dr. Answer AI for Prostate Cancer: Predicting Biochemical Recurrence Following Radical Prostatectomy Park1, J; Rho, MJ; Moon, HW; Kim, J; Lee, C; Kim, D; Kim, CS; Jeon, SS; Kang, M; Lee, JY
    View PubMed
  • CURR ISSUES MOL BIOL 2021 10.3390/cimb43010019 Renal Cell Carcinoma-Infiltrating CD3(low) V gamma 9V delta 1 T Cells Represent Potentially Novel Anti-Tumor Immune Players Lee1, HW; Park, C; Joung, JG; Kang, MY; Chung, YS; Oh, WJ; Yeom, SY; Park, WY; Kim, TJ; Seo, SI
    View PubMed
  • PLOS ONE 2021 10.1371/journal.pone.0249709 Biochemical recurrence after radical prostatectomy according to nadir prostate specific antigen value Chung1, JH; Jeong, JY; Lee, JY; Song, W; Kang, M; Sung, HH; Jeon, HG; Jeong, BC; Seo, SI; Lee, HM; Jeon, SS
    View PubMed
  • SCI REP-UK 2021 10.1038/s41598-021-87573-5 Comparison of oncologic and functional outcomes between radical nephroureterectomy and segmental ureterectomy for upper urinary tract urothelial carcinoma Kim1, TH; Lee, CU; Kang, M; Jeon, HG; Jeong, BC; Seo, SI; Jeon, SS; Lee, HM; Sung, HH
    View PubMed
  • BIOLOGY-BASEL 2021 10.3390/biology10040297 Assessment of Agreement between Two Difference Prostate-Specific Antigen Assay Modalities Chung1, JH; Park, M; Cho, H; Song, W; Kang, M; Sung, HH; Jeon, HG; Jeong, BC; Seo, SI; Lee, HM; Jeon, SS
    View PubMed
  • PROSTATE INT 2021 10.1016/j.prnil.2020.06.003 Prostate cancer trajectory-map: clinical decision support system for prognosis management of radical prostatectomy Park1, J; Rho, MJ; Moon, HW; Park, YH; Kim, CS; Jeon, SS; Kang, M; Lee, JY
    View PubMed
  • SCI REP-UK 2021 10.1038/s41598-021-85099-4 Potential of circulating tumor DNA as a predictor of therapeutic responses to immune checkpoint blockades in metastatic renal cell carcinoma Kim1, YJ; Kang, Y; Kim, JS; Sung, HH; Jeon, HG; Jeong, BC; Seo, SI; Jeon, SS; Lee, HM; Park, D; Park, WY; Kang, M
    View PubMed
  • INVESTIG CLIN UROL 2021 10.4111/icu.20200406 Genomic mutation profiling using liquid biopsy in Korean patients with prostate cancer: Circulating tumor DNA mutation predicts the development of castration resistance Yu1, J; Cho, E; Choi, J; Lim, JE; Lee, J; Kang, M; Sung, HH; Jeong, BC; Seo, SI; Jeon, SS; Lee, HM; Jeon, HG
    View PubMed
  • INT J UROL 2021 10.1111/iju.14485 Targeted therapy response in early versus late recurrence of renal cell carcinoma after surgical treatment: A propensity score-matched study using the Korean Renal Cancer Study Group database Lee1, CH; Chung, J; Kwak, C; Jeong, CW; Seo, SI; Kang, M; Hong, SH; Song, C; Park, JY; Hwang, EC; Lee, H; Ku, JY; Seo, WI; Choi, SH; Ha, HK
    View PubMed
  • NATURE 2020 10.1038/s41586-020-3034-x Creation of bladder assembloids mimicking tissue regeneration and cancer Kim1, E; Choi, S; Kang, B; Kong, J; Kim, Y; Yoon, WH; Lee, HR; Kim, S; Kim, HM; Lee, H; Yang, C; Lee, YJ; Kang, M; Roh, TY; Jung, S; Kim, S; Ku, JH; Shin, K
    View PubMed
  • INVESTIG CLIN UROL 2020 10.4111/icu.20200084 Correlation between Gleason score distribution and Prostate Health Index in patients with prostate-specific antigen values of 2.5-10 ng/mL Choi1, J; Kang, M; Sung, HH; Jeon, HG; Jeong, BC; Seo, SI; Jeon, SS; Lee, HM
    View PubMed
  • J SURG ONCOL 2020 10.1002/jso.26251 Metastatic renal cell carcinoma to the pancreas Clinical features and treatment outcome Shin1, TJ; Song, C; Jeong, CW; Kwak, C; Seo, S; Kang, M; Chung, J; Hong, SH; Hwang, EC; Park, JY; Lee, H
    View PubMed
  • J KOREAN MED SCI 2020 10.3346/jkms.2020.35.e342 Strategy for Prostate Cancer Patients with Low Prostate Specific Antigen Level (2.5 to 4.0 ng/mL) Chung1, JH; Yu, J; Song, W; Kang, M; Sung, HH; Jeon, HG; Jeong, BC; Seo, SI; Lee, HM; Jeon, SS
    View PubMed
  • J CANCER 2020 10.7150/jca.48062 Prognostic Impact of Bone Metastasis on Survival Outcomes in Patients with Metastatic Renal Cell Carcinoma Treated by First Line Tyrosine Kinase Inhibitors A Propensity-Score Matching Analysis Kang1, M; Choi, J; Kim, J; Sung, HH; Jeon, HG; Jeong, BC; Jeon, SS; Lee, HM; Park, SH; Song, C; Seo, SI
    View PubMed
  • EBIOMEDICINE 2020 10.1016/j.ebiom.2020.102986 Autophagy induction promotes renal cyst growth in polycystic kidney disease Lee1, EJ; Ko, JY; Oh, S; Jun, J; Mun, H; Lim, CJ; Seo, S; Ko, HW; Kim, H; Oh, YK; Ahn, C; Kang, M; Kim, MJ; Yoo, KH; Oh, GT; Park, JH
    View PubMed
  • PROSTATE INT 2020 10.1016/j.prnil.2020.03.003 Detection of prostate cancer using prostate imaging reporting and data system score and prostate-specific antigen density in biopsy-naive and prior biopsy-negative patients Ryoo1, H; Kang, MY; Sung, HH; Jeong, BC; Seo, SI; Jeon, SS; Lee, HM; Jeon, HG
    View PubMed
  • INT J SURG 2020 10.1016/j.ijsu.2020.07.006 Relationship between robotic-assisted radical prostatectomy and retropubic radical prostatectomy in the learning curve of a single surgeon as a novice in radical prostatectomy A retrospective cohort study Song1, W; Lee, SW; Chung, JH; Kang, M; Sung, HH; Jeon, HG; Jeong, BC; Seo, SI; Lee, HM; Jeon, SS
    View PubMed
  • INVESTIG CLIN UROL 2020 10.4111/icu.20200002 The platelet-to-lymphocyte ratio as a significant prognostic factor to predict survival outcomes in patients with synchronous metastatic renal cell carcinoma Yuk1, HD; Kang, M; Hwang, EC; Park, JY; Jeong, CW; Song, C; Seo, SI; Byun, SS; Kwak, C; Hong, SH; Chung, J; Lee, H
    View PubMed
  • PLOS ONE 2020 10.1371/journal.pone.0236553 Dr. Answer AI for prostate cancer Clinical outcome prediction model and service Rho1, MJ; Park, J; Moon, HW; Lee, C; Nam, S; Kim, D; Kim, CS; Jeon, SS; Kane, M; Lee, JY
    View PubMed
  • DIS MARKERS 2020 10.1155/2020/8887605 Clinical Significance of Pre-to-Postoperative Dynamics of Aspartate Transaminase/Alanine Transaminase Ratio in Predicting the Prognosis of Renal Cell Carcinoma after Surgical Treatment Kang1, M; Shin, SJ; Sung, HH; Jeon, HG; Jeong, BC; Jeon, SS; Lee, HM; Seo, SI
    View PubMed
  • J HEPATOL 2020 10.1016/j.jhep.2020.01.010 Functions of human liver CD69(+)CD103(-)CD8(+) T cells depend on HIF-2 alpha activity in healthy and pathologic livers Kim1, JH; Han, JW; Choi, YJ; Rha, MS; Koh, JY; Kim, KH; Kim, CG; Lee, YJ; Kim, AR; Park, J; Kim, HK; Min, BS; Il Seo, S; Kang, M; Park, HJ; Han, DH; Il Kim, S; Kim, MS; Lee, JG; Lee, DH; Kim, W; Park, JY; Park, SH; Joo, DJ; Shin, EC
    View PubMed
  • INVESTIG CLIN UROL 2020 10.4111/icu.2020.61.1.19 Enzalutamide in chemotherapy-naive patients with metastatic castration-resistant prostate cancer: A retrospective Korean multicenter study in a real-world setting Jung1, SI; Kim, MS; Jeong, CW; Kwak, C; Hong, SK; Kang, SH; Joung, JY; Lee, SH; Yun, SJ; Kim, TH; Park, SW; Jeon, SS; Kang, M; Lee, JY; Chung, BH; Hong, JH; Ahn, H; Kim, CS; Kwon, DD
    View PubMed
  • CLIN GENITOURIN CANC 2019 10.1016/j.clgc.2019.07.014 Novel Predictive Models of Early Death Less Than 1 Year in Patients With Metastatic Renal Cell Carcinoma After Treatment With First-line Tyrosine Kinase Inhibitors Shin1, SJ; Kim, T; Sung, HH; Jeon, HG; Jeong, BC; Park, SH; Jeon, SS; Lee, HM; Choi, HY; Seo, SI; Kang, M
    View PubMed
  • INVESTIG CLIN UROL 2019 10.4111/icu.2019.60.6.454 The clinical utility of transperineal template-guided saturation prostate biopsy for risk stratification after transrectal ultrasound-guided biopsy Song1, W; Kang, M; Jeong, BC; Seo, SI; Jeon, SS; Lee, HM; Jeon, HG
    View PubMed
  • J ENDOUROL 2019 10.1089/end.2019.0410 Comparison by Pentafecta Criteria of Transperitoneal and Retroperitoneal Robotic Partial Nephrectomy for Large Renal Tumors Choi1, CI; Kang, M; Sung, HH; Jeon, HG; Jeong, BC; Jeon, SS; Lee, HM; Seo, SI
    View PubMed
  • WORLD J UROL 2019 10.1007/s00345-018-02617-2 Combination of multiparametric magnetic resonance imaging and transrectal ultrasound-guided prostate biopsies is not enough for identifying patients eligible for hemiablative focal therapy for prostate cancer Choi1, YH; Yu, JW; Kang, MY; Sung, HH; Jeong, BC; Seo, SI; Jeon, SS; Lee, HM; Jeon, HG
    View PubMed
  • UROL INT 2019 10.1159/000501527 Cancer Location in Upgrading and Detection after Transperineal Template-Guided Mapping Biopsy for Patients in Active Surveillance and Negative Transrectal Ultrasonography-Guided Prostate Biopsy Lee1, CU; Sung, SH; Jang, CT; Kang, M; Sung, HH; Jeong, BC; Il Seo, S; Jeon, SS; Lee, HM; Jeon, HG
    View PubMed
  • CANCER RES TREAT 2019 10.4143/crt.2018.604 Atezolizumab in Patients with Pretreated Urothelial Cancer: A Korean Single-Center, Retrospective Study Hur1, JY; Kim, Y; Kwon, GY; Kang, M; Sung, HH; Jean, HG; Jeong, BC; Seo, SI; Jean, SS; Lee, HM; Lee, SJ; Park, SH
    View PubMed
  • APPL SCI-BASEL 2019 10.3390/app9152982 PROMISE CLIP Project: A Retrospective, Multicenter Study for Prostate Cancer that Integrates Clinical, Imaging and Pathology Data Park1, J; Rho, MJ; Park, YH; Jung, CK; Chong, Y; Kim, CS; Go, H; Jeon, SS; Kang, M; Lee, HJ; Hwang, SI; Lee, JY
    View PubMed
  • INVESTIG CLIN UROL 2019 10.4111/icu.2019.60.4.227 Genomic analysis of Korean patients with advanced prostate cancer by use of a comprehensive next-generation sequencing panel and low-coverage, whole-genome sequencing Kang1, M; Cho, E; Jang, J; Lee, J; Jeon, Y; Jeong, BC; Seo, SI; Jeon, SS; Lee, HM; Choi, HY; Jeon, HG
    View PubMed
  • Cancer Manag Res 2019 10.2147/CMAR.S199432 Predictors of postoperative complications after robot-assisted radical cystectomy with extracorporeal urinary diversion Lee1, CU; Kang, M; Kim, TJ; Na, JP; Sung, HH; Jeon, HG; Seo, S; Jeon, SS; Lee, HM; Jeong, BC
    View PubMed
  • BMC UROL 2019 10.1186/s12894-019-0463-7 A retrospective feasibility study of biweekly docetaxel in patients with high-risk metastatic castration-naive prostate cancer Yoon1, SE; Kim, Y; Cho, J; Kang, M; Sung, HH; Jeon, HG; Jeong, BC; Seo, SI; Jeon, SS; Lee, HM; Choi, HY; Lee, SJ; Park, SH
    View PubMed
  • eLife 2019 10.7554/eLife.43024 Epigenetic regulation of mammalian Hedgehog signaling to the stroma determines the molecular subtype of bladder cancer Kim1, S; Kim, Y; Kong, J; Kim, E; Choi, JH; Yuk, HD; Lee, H; Kim, HR; Lee, KH; Kang, M; Roe, JS; Moon, KC; Kim, S; Ku, JH; Shin, K
    View PubMed
  • PROSTATE CANCER P D 2019 10.1038/s41391-018-0088-z Importance of androgen-deprivation therapy during enzalutamide treatment in men with metastatic castration-resistant prostate cancer following chemotherapy: results from retrospective, multicenter data Jeong1, CW; Kang, M; Jung, SI; Kim, TH; Park, SW; Joung, JY; Jeon, SS; Hong, JH; Lee, JY; Chung, BH; Ahn, H; Kim, CS; Kwon, DD; Kwak, C
    View PubMed
  • CLIN GENITOURIN CANC 2019 10.1016/j.clgc.2018.09.007 Comparison of Cancer Detection Rates Between TRUS-Guided Biopsy and MRI-Targeted Biopsy According to PSA Level in Biopsy-Naive Patients: A Propensity Score Matching Analysis Choi1, YH; Kang, MY; Sung, HH; Eon, HG; Jeong, BC; Seo, SI; Jeon, SS; Kim, CK; Park, BK; Lee, HM
    View PubMed
  • Cancer Manag Res 2019 10.2147/CMAR.S185796 Incidences and oncological outcomes of urothelial carcinoma in kidney transplant recipients Yu1, J; Lee, CU; Kang, M; Jeon, HG; Jeong, BC; Seo, SI; Jeon, SS; Lee, HM; Sung, HH
    View PubMed
  • Prostate Cancer Prostatic Dis. 2018 Sep 13 Importance of androgen-deprivation therapy during enzalutamide treatment in men with metastatic castration-resistant prostate cancer following chemotherapy: results from retrospective, multicenter data Jeong CW1, Kang M, Il Jung S, Kim TH, Park SW, Joung JY, Jeon SS, Hong JH, Lee JY, Chung BH, Ahn H, Kim CS, Kwon DD, Kwak C
  • J Urol. 2018 Jun 22 Changeable conditional survival rates and associated prognosticators in patients with metastatic renal cell carcinoma receiving first-line targeted therapy. Kang M1, Park JY, Jeong CW, Hwang EC, Song C, Hong SH, Kwak C, Chung J, Sung HH, Jeon HG, Jeong BC1, Park SH, Jeon SS, Lee HM, Choi HY, Seo SI.
  • Int J Urol. 2018 Jun Prognostic impact of the pretreatment aspartate transaminase/alanine transaminase ratio in patients treated with first-line systemic tyrosine kinase inhibitor therapy for metastatic renal cell carcinoma. Kang M1, Yu J, Sung HH, Jeon HG, Jeong BC, Park SH, Jeon SS, Lee HM, Choi HY, Seo SI.
  • World J Mens Health. 2018 Jan. Clinical Significance of Serum Adipokines according to Body Mass Index in Patients with Clinically Localized Prostate Cancer Undergoing Radical Prostatectomy Kang M1, Byun SS, Lee SE, Hong SK
  • Int J Cancer. 2018 Sep 5 Histone demethylase KDM7A controls androgen receptor activity and tumor growth in prostate cancer Lee KH1, Hong S, Kang M, Jeong CW, Ku JH, Kim HH, Kwak C
  • Oncology letters. 2018 Jan. Anticancer effect of S-allyl-L-cysteine via induction of apoptosis in human bladder cancer cells Ho JN1, Kang M (co-primary author), Lee S, Oh JJ, Hong SK, Lee SE, Byun SS
  • INT J CANCER 2018 10.1002/ijc.31843 Histone demethylase KDM7A controls androgen receptor activity and tumor growth in prostate cancer Lee1, KH; Hong, S; Kang, M; Jeong, CW; Ku, JH; Kim, HH; Kwak, C
    View PubMed
  • CLIN GENITOURIN CANC 2018 10.1016/j.clgc.2018.07.030 Oncologic Outcomes of Cytoreductive Nephrectomy in Synchronous Metastatic Renal-Cell Carcinoma: A Single-Center Experience Choi1, CI; Kang, M; Sung, HH; Jeon, HG; Jeong, BC; Jeon, SS; Lee, HM; Seo, SIL
    View PubMed
  • CANCER RES TREAT 2018 10.4143/crt.2017.248 Effects of Aspirin, Nonsteroidal Anti-inflammatory Drugs, Statin, and COX2 Inhibitor on the Developments of Urological Malignancies: A Population-Based Study with 10-Year Follow-up Data in Korea Kang1, M; Ku, JH; Kwak, C; Kim, HH; Jeong, CW
    View PubMed
  • EUR RADIOL 2018 10.1007/s00330-018-5305-6 RFA versus robotic partial nephrectomy for T1a renal cell carcinoma: a propensity score-matched comparison of mid-term outcome Park1, BK; Gong, IH; Kang, MY; Sung, HH; Jeon, HG; Jeong, BC; Jeon, SS; Lee, HM; Seo, SI
    View PubMed
  • INT J UROL 2018 10.1111/iju.13574 Prognostic impact of the pretreatment aspartate transaminase/alanine transaminase ratio in patients treated with first-line systemic tyrosine kinase inhibitor therapy for metastatic renal cell carcinoma Kang1, M; Yu, J; Sung, HH; Jeon, HG; Jeong, BC; Park, SH; Jeon, SS; Lee, HM; Choi, HY; Seo, SI
    View PubMed
  • World J Mens Health 2018 10.5534/wjmh.17026 Clinical Significance of Serum Adipokines according to Body Mass Index in Patients with Clinically Localized Prostate Cancer Undergoing Radical Prostatectomy Kang1, M; Byun, SS; Lee, SE; Hong, SK
    View PubMed
  • ONCOL LETT 2018 10.3892/ol.2017.7280 Anticancer effect of S-allyl-L-cysteine via induction of apoptosis in human bladder cancer cells Ho1, JN; Kang, M; Lee, S; Oh, JJ; Hong, SK; Lee, SE; Byun, SS
    View PubMed
  • Mol Cell Biol. 2017 Aug 21 RNF20 Suppresses Tumorigenesis by Inhibiting SREBP1c-PTTG1 Axis in Kidney Cancer. Lee JH1, Jeon YG, Lee KH, Lee HW, Park J, Jang H, Kang M, Lee HS, Cho HJ, Nam DH, Kwak C, Kim JB.
  • Ann Surg Oncol. 2017 Dec. Prognostic Significance of Pre- to Postoperative Dynamics of the Prognostic Nutritional Index for Patients with Renal Cell Carcinoma Who Underwent Radical Nephrectomy Kang M1, Chang CT, Sung HH, Jeon HG, Jeong BC, Seo SI, Jeon SS, Choi HY, Lee HM
  • Int J Mol Sci. 2017 Feb. Concurrent Autophagy Inhibition Overcomes the Resistance of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Human Bladder Cancer Cells Kang M1, Lee KH, Lee HS, Jeong CW, Kwak C, Kim HH, Ku JH
  • Clin Genitourin Cancer. 2017 Jan 12. Prognostic Role of Neutrophil-to-lymphocyte Ratio-based Markers During Pre- and Postadjuvant Chemotherapy in Patients With Advanced Urothelial Carcinoma of Upper Urinary Tract Kang M1, Jeong CW, Kwak C, Kim HH, Ku JH
  • Oncotarget. 2017 Feb. Preoperative neutrophil-lymphocyte ratio can significantly predict mortality outcomes in patients with non-muscle invasive bladder cancer undergoing transurethral resection of bladder tumor Kang M1, Chang Wook Jeong, Cheol Kwak, Hyeon Hoe Kim, Ja Hyeon Ku
  • J Endourol. 2017 Dec. Predictive Factors for Achieving Superior Pentafecta Outcomes Following Robot-Assisted Partial Nephrectomy in Patients with Localized Renal Cell Carcinoma Kang M1, Gong IH, Park HJ, Sung HH, Jeon HG, Jeong BC, Jeon SS, Lee HM, Choi HY, Seo SI
  • Cancer Res Treat. 2017 Oct 27. Effects of Aspirin, Nonsteroidal Anti-inflammatory Drugs, Statin and COX2 Inhibitor on the Developments of Urological Malignancies: A Population-Based Study with 10-Year Follow-up Data in Korea Kang M1, Ku JH, Kwak C, Kim HH, Jeong CW
  • Clin Genitourin Cancer. 2017 Jan. Can the preoperative neutrophil-lymphocyte significantly predict the conditional survival probability in muscle-invasive bladder cancer patients undergoing radical cystectomy? Kang M1, Ulanbek J. Balpukov, Chang Wook Jeong, Cheol Kwak, Hyeon Hoe Kim, Ja Hyeon Ku
  • PLoS One. 2017 Sep. Concurrent treatment with simvastatin and NF-κB inhibitor in human castration-resistant prostate cancer cells exerts synergistic anti-cancer effects via control of the NF-κB/LIN28/let-7 miRNA signaling pathway Kang M1, Lee KH, Lee HS, Jeong CW, Ku JH, Kim HH, Kwak C.
  • Oncotarget. 2017 May Comparing the clinical efficacy of abiraterone acetate, enzalutamide, and orteronel in patients with metastatic castration-resistant prostate cancer by performing a network meta-analysis of eight randomized controlled trials Kang M1, Jeong CW, Kwak C, Ku JH, Kim HH
  • ANN SURG ONCOL 2017 10.1245/s10434-017-6065-2 y Prognostic Significance of Pre- to Postoperative Dynamics of the Prognostic Nutritional Index for Patients with Renal Cell Carcinoma Who Underwent Radical Nephrectomy Kang1, M; Chang, CT; Sung, HH; Jeon, HG; Jeong, BC; Seo, SI; Jeon, SS; Choi, HY; Lee, HM
    View PubMed
  • J ENDOUROL 2017 10.1089/end.2017.0369 Predictive Factors for Achieving Superior Pentafecta Outcomes Following Robot-Assisted Partial Nephrectomy in Patients with Localized Renal Cell Carcinoma Kang1, M; Gong, IH; Park, HJ; Sung, HH; Jeon, HG; Jeong, BC; Jeon, SS; Lee, HM; Choi, HY; Seo, SI
    View PubMed
  • PLoS One 2017 10.1371/journal.pone.0184644 Concurrent treatment with simvastatin and NF-kB inhibitor in human castration-resistant prostate cancer cells exerts synergistic anticancer effects via control of the NF-kB/LIN28/let-7 miRNA signaling pathway Kang1, M; Lee, KH; Lee, HS; Jeong, CW; Ku, JH; Kim, HH; Kwak, C
    View PubMed
  • ONCOTARGET 2017 10.18632/oncotarget.17741 Comparing the clinical efficacy of abiraterone acetate, enzalutamide, and orteronel in patients with metastatic castration-resistant prostate cancer by performing a network meta-analysis of eight randomized controlled trials Kang1, M; Jeong, CW; Kwak, C; Ku, JH; Kim, HH
    View PubMed
  • Ann Surg Oncol. 2016 Mar 10. Perineural Invasion and Lymphovascular Invasion are Associated with Increased Risk of Biochemical Recurrence in Patients Undergoing Radical Prostatectomy. Kang M1, Oh JJ, Lee S, Hong SK, Lee SE, Byun SS.
  • World J Urol. 2016 Mar 21. Clearance rates of residual stone fragments and dusts after endoscopic lithotripsy procedures using a holmium laser: 2-year follow-up results. Kang M1, Son H, Jeong H, Cho MC, Cho SY.
  • Translational Cancer Research. 2016 Sep. Durvalumab (MEDI4736; anti-PD-L1 inhibitor): to shed light on the treatment of advanced urothelial bladder cancer patients refractory to systemic chemotherapy Kang M1,, Ja Hyeon Ku.
  • Prostate. 2016 Feb. PDLIM2 suppression efficiently reduces tumor growth and invasiveness of human castration-resistant prostate cancer-like cells. Kang M1, Kyoung-Hwa Lee, Hye Sun Lee, Kyoung-Hwa Lee, Yong Hyun Park, Chang Wook Jeong, Ja Hyeon Ku1, Hyeon Hoe Kim1 and Cheol Kwak.
  • World J Urol. 2016 Apr 13. Predictors of pathological upgrading in low-risk prostate cancer patients without hypointense lesions on an apparent diffusion coefficient map of multiparametric magnetic resonance imaging Kang M1, Song B, Lee I, Lee SE, Byun SS, Hong SK
  • Clin Genitourin Cancer. 2016 Aug. Do Second Primary Cancers Affect the Risk of Biochemical Recurrence in Prostate Cancer Patients Undergoing Radical Prostatectomy? A Propensity Score-Matched Analysis. Kang M1, Jung JW, Oh JJ, Lee S, Hong SK, Lee SE, Byun SS
  • Oncotarget. 2016 Jun 14. Single, immediate postoperative instillation of chemotherapy in non-muscle invasive bladder cancer: a systematic review and network meta-analysis of randomized clinical trials using different drugs Kang M1, Jeong CW, Kwak C, Kim HH, Ku JH
  • Urology. 2015 Jan. S100A3 suppression inhibits in vitro and in vivo tumor growth and invasion of human castration-resistant prostate cancer cells. Kang M1, Hye Sun Lee, Young Ju Lee, Woo Suk Choi, Yong Hyun Park, Chang Wook Jeong, Ja Hyeon Ku, Hyeon Hoe Kim and Cheol Kwak.
  • Int J Urol. 2015 Jan 12. Characteristics and significant predictors of detecting underlying diseases in adults with asymptomatic microscopic hematuria: A large case series of a Korean population. Kang M1, Sangchul Lee, Seong Jin Jeong, Sung Kyu Hong, Seok-Soo Byun, Sang Eun Lee and Chang Wook Jeong.
  • Yonsei Med J. 2015 Mar. The characteristics of recurrent upper tract urothelial carcinoma after radical nephroureterectomy without bladder cuff excision: a single-institution experience. Kang M1, Chang Wook Jeong, Cheol Kwak, Hyeon Hoe Kim and Ja Hyeon Ku.
  • PLoS One. 2015 Mar. Hypertriglyceridemia is a potential preoperative predictor for biochemical recurrence after radical prostatectomy. Kang M1, Chang Wook Jeong, Cheol Kwak, Hyeon Hoe Kim and Ja Hyeon Ku.
  • Annals of Surgical Oncology 2015 Jul 8. The prognostic significance of early postoperative neutrophil-to-lymphocyte ratio in patients with urothelial carcinoma of the bladder undergoing radical cystectomy. Kang M1, Chang Wook Jeong, Cheol Kwak, Hyeon Hoe Kim and Ja Hyeon Ku.
  • Sci Rep. 2015 Jul. Prognostic factors for conditional survival in patients with muscle-invasive urothelial carcinoma of the bladder treated with radical cystectomy. Kang M1, Hyung Suk Kim Chang Wook Jeong, Cheol Kwak, Hyeon Hoe Kim and Ja Hyeon Ku.
  • J Korean Med Sci. 2015 Aug. Survival Outcomes and Predictive Factors for Female Urethral Cancer: Long-term Experience with Korean Patients. Kang M1, Chang Wook Jeong, Cheol Kwak, Hyeon Hoe Kim and Ja Hyeon Ku.
  • J Urol. 2015 Nov 7. Predictive Factors of Chronic Kidney Disease in Patients with Vesicoureteral Reflux Treated by Surgery and Followed until Post-puberty. Kang M1, Jung Keun Lee, Young Jae Im, Hwang Choi, Kwanjin Park.
  • Oncology Reports. 2015 Dec 29. Theracumin efficiently inhibits growth of human prostate and bladder cancer cells via induction of apoptotic cell death and cell cycle arrest. Kang M1, Ho JN, Kook HR, Lee S, Oh JJ, Hong SK, Lee SE, Byun SS.
  • Urology. 2016 Mar. Urodynamic features and significant predictors of bladder outlet obstruction in patients with lower urinary tract symptoms/benign prostatic hyperplasia and small prostate volume. Kang M1, Kim M, Choo MS, Paik JS, Oh SJ.
  • Cancer Research and Treatment. 2015 Sep 9. Conditional survival and associated prognostic factors in the patients with upper tract urothelial carcinoma after radical nephroureterectomy: A retrospective study of single institutional experience. Kang M1, Chang Wook Jeong, Cheol Kwak, Hyeon Hoe Kim, and Ja Hyeon Ku.
  • PLoS One. 2014 Jun. Pre- and post-operative nomograms to predict recurrence-free probability in Korean men with clinically localized prostate cancer. Kang M1, Chang Wook Jeong, Woo Suk Choi, Yong Hyun Park, Sung Yong Cho, Sangchul Lee, Seung Bae Lee, Ja Hyeon Ku, Sung Kyu Hong, Seok-Soo Byun, Hyeon Jeong, Cheol Kwak, Hyeon Hoe Kim, Eunsik Lee, Sang Eun Lee; Seoul National University-Uro-Oncology Group).
  • Int J Mol Sci. 2014 Apr. Generation of Bladder Urothelium from Human Pluripotent Stem Cells under Chemically Defined Serum- and Feeder-Free System. Kang M1, Hyeon Hoe Kim and Yong-Mahn Han.
  • Urology. 2014 Dec Association of high bladder neck elevation with urodynamic bladder outlet obstruction in patients with lower urinary tract symptoms and benign prostatic hyperplasia. Kang M1, Myong Kim, Min Soo Choo, Jungbum Bae, Ja Hyeon Ku.
  • PLoS One. 2014 Apr. Differentiation of human pluripotent stem cells into nephron progenitor cells in a serum and feeder free system. 1,Kang M and Yong-Mahn Han.
  • Int J Mol Sci. 2014 May. Inhibition of autophagy potentiates atorvastatin-induced apoptotic cell death in human bladder cancer cells in vitro. Kang M1, Chang Wook Jeong, Ja Hyeon Ku, Choel Kwak and Hyeon Hoe Kim.
  • Yonsei Medical Journal. 2012 Jan. Preventive Effects of Green Tea (Camellia Sinensis var. Assamica) on Diabetic Nephropathy. Kang M1, Yong Hyun Park, Bong Sub Kim, Su Yeon Seo, Byong Chang Jeong, Jung-In Kim, and Hyeon Hoe Kim.
  • J Korean Med Sci. 2010 Feb. Non-invasive parameters predicting bladder outlet obstruction in Korean men with lower urinary tract symptoms. Kang M1, Ja Hyeon Ku, and Seung-June Oh.